A Mutant Form of Human Protein Farnesyltransferase Exhibits Increased Resistance to Farnesyltransferase Inhibitors

Journal of Biological Chemistry- United States

doi 10.1074/jbc.274.38.27010

Full Text

Abstract

Available in

Categories

Molecular Biology

Date

September 17, 1999

Authors

Keith Del Villar

Fuyuhiko Tamanoi

Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Resistance to a Protein Farnesyltransferase Inhibitor inPlasmodium Falciparum

Journal of Biological Chemistry

Molecular Biology

English

High Affinity for Farnesyltransferase and Alternative Prenylation Contribute Individually to K-Ras4B Resistance to Farnesyltransferase Inhibitors

Journal of Biological Chemistry

Molecular Biology

English

Farnesyltransferase Inhibitors: A New Class of Cancer Chemotherapeutics

Biochemical Society Transactions

English

The Potential of Farnesyltransferase Inhibitors as Cancer Chemotherapeutics

Annual Review of Pharmacology and Toxicology

English

Tetrapeptide Inhibitors of Protein Farnesyltransferase: Amino-Terminal Substitution in Phenylalanine-Containing Tetrapeptides Restores Farnesylation.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

RhoB Alteration Is Necessary for Apoptotic and Antineoplastic Responses to Farnesyltransferase Inhibitors

Molecular and Cellular Biology

Molecular Biology

English

New Targeted Therapies in Myelodysplastic Syndrome: The Role of Farnesyltransferase and Proteasome Inhibitors

BMC Proceedings

Molecular Biology

English

Quantitative Structure-Activity Relationships of Imidazole-Containing Farnesyltransferase Inhibitors Using Different Chemometric Methods

Medicinal Chemistry

English

RhoB and the Cellular Response to Farnesyltransferase Inhibitors: The Search for Clues to Cell Death Mechanisms

Cancer Biology and Therapy

Cancer Research

Molecular Medicine

English